-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 U25LxsE1P0fMHE1XR0JxmPrDPJvVeBkrVJ6dOFsjuEa/2LzMzFt9RbGE+7ZAfrEo
 EZ26jDdqHDfLqZEHHiGhyA==

<SEC-DOCUMENT>0000897069-98-000354.txt : 19980624
<SEC-HEADER>0000897069-98-000354.hdr.sgml : 19980624
ACCESSION NUMBER:		0000897069-98-000354
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		19980623
SROS:			NASD

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOMERICA INC
		CENTRAL INDEX KEY:			0000073290
		STANDARD INDUSTRIAL CLASSIFICATION:	DENTAL EQUIPMENT & SUPPLIES [3843]
		IRS NUMBER:				952645573
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0531

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		
		SEC FILE NUMBER:	333-19977
		FILM NUMBER:		98652277

	BUSINESS ADDRESS:	
		STREET 1:		1533 MONROVIA AVENUE
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92663
		BUSINESS PHONE:		714-645-2111

	MAIL ADDRESS:	
		STREET 1:		1533 MONROVIA AVENUE
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92663

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NMS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19871130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUCLEAR MEDICAL SYSTEMS INC
		DATE OF NAME CHANGE:	19830216

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUCLEAR INSTRUMENTS INC
		DATE OF NAME CHANGE:	19720508
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<DESCRIPTION>FILED PURSUANT TO RULE 424(B)(3)
<TEXT>


                      Filed Pursuant to Rule 424(b)(3)
                           Registration No. 333-19977

PROSPECTUS SUPPLEMENT DATED JUNE 22, 1998

(To Prospectus dated October 21, 1997)

                                   PROSPECTUS

                                 333,333 SHARES

                                BIOMERICA , INC.
                                  COMMON STOCK

This Prospectus Supplement together,  with the Prospectus listed above, is to be
used by  certain  holders  of the  above-referenced  common  stock  or by  their
transferees,  pledgees, donees, or their successors in connection with the offer
and sale of the above referenced common stock.

<PAGE>   2

                                               SELLING STOCKHOLDERS

The  table  captioned  "Selling  Stockholders"  commencing  on  page  7  of  the
Prospectus is hereby amended to reflect the following changes.


                           TOTAL SHARES OF COMPANY     NUMBER OF SHARES OFFERED
                           STOCK BENEFICIALLY OWNED
                          

NAME
The Aries Fund, A Cayman
  Island Trust                       222,222                   222,222
The Aries Domestic Fund,
   L.P.(1)                           111,111                   111,111
                                     -------                   -------
Total                                333,333                   333,333



(1) The investment manager of The Aries Fund, A Cayman Island Trust, is 
Paramount Capital Asset Management, Inc., a subchapter S corporation 
("Paramount Capital"). The general partner of The Aries Domestic Fund, L.P. is
Paramount Capital. The sole stockholder of Paramount Capital is Lindsay A.
Rosenwald, M.D.

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
